Etiology, clinical presentation, outcome and the effect of initial management in immunocompromised patients with community acquired bacterial meningitis
| Autor: | Pontus Naucler, Jan Sjölin, Martin Glimåker |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
0301 basic medicine
Microbiology (medical) Adult medicine.medical_specialty medicine.drug_class 030106 microbiology Antibiotics Meningitis Listeria medicine.disease_cause Meningitis Bacterial 03 medical and health sciences Immunocompromised Host 0302 clinical medicine Internal medicine Streptococcus pneumoniae Clinical endpoint Medicine Humans 030212 general & internal medicine Sweden business.industry Odds ratio Confidence interval Anti-Bacterial Agents Infectious Diseases Etiology Bacterial meningitis Presentation (obstetrics) business |
| Zdroj: | The Journal of infection. 80(3) |
| ISSN: | 1532-2742 |
| Popis: | Objectives . The aim was to analyze differences in clinical presentation, etiology, management, and outcome between immunocompromised and immunocompetent patients with acute bacterial meningitis (ABM). Methods . Data were extracted from 1056 adult ABM patients prospectively registered in the national Swedish quality register for ABM during 2008-2017. Primary endpoint was 30-day mortality and secondary endpoints 90-day mortality and unfavourable outcome. Results . An immunocompromised state was observed in 352 (33%) of the 1056 patients. Streptococcus pneumoniae dominated in both immunocompromised and immunocompetent patients (53% in both groups), whereas L monocytogenes occurred in 11% and 2%, respectively. The unadjusted odds ratio (OR) for 30-day mortality in immunocompromised compared to immunocompetent patients was 1.68 (95% confidence interval (CI): 1.07-2.63). Adjusted for age, sex, and mental status on admission the OR was 1.34 (CI: 0.82-2.21). Adjusted also for time to antibiotic treatment and corticosteroids the OR was 1.10 (CI: 0.59-2.05), and in patients without Listeria meningitis 0.98 (CI: 0.50-1.90). Although, the ORs were higher for 90-day mortality and unfavourable outcome the effects of adjustments were similar. Conclusion . Mortality in immunocompromised patients with ABM is only moderately increased unless caused by Listeria. This difference is further reduced in patients given early antibiotic treatment and adjunctive corticosteroids. Funding : This work was supported by Stockholm County Council. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect